|
| 37296834 | Cellular and Molecular Mechanisms of Liver Fibrosis in Patients with NAFLD. | | 2023 |
| 36162136 | Treatment Strategies and Mechanisms Associated with the Prevention of NASH-Associated HCC by a Toll-like Receptor 4 Inhibitor. | Cancer Prev Res (Phila) | 2023 |
| 37568603 | Gender Differences in a Mouse Model of Hepatocellular Carcinoma Revealed Using Multi-Modal Imaging. | Cancers (Basel) | 2023 |
| 36710882 | Plasma enzymatic activity, proteomics and peptidomics in COVID-19-induced sepsis: A novel approach for the analysis of hemostasis. | Front Mol Biosci | 2023 |
| 37329887 | Molecular mechanisms of snoRNA-IL-15 crosstalk in adipocyte lipolysis and NK cell rejuvenation. | Cell Metab | 2023 |
| 36687470 | Spatial molecular and cellular determinants of STAT3 activation in liver fibrosis progression in non-alcoholic fatty liver disease. | | 2023 |
| 35065057 | Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial. | Lancet Gastroenterol Hepatol | 2022 |
| 35477306 | Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas. | mSystems | 2022 |
| 36386790 | Genetic variants associated with circulating liver injury markers in Mexican Americans, a population at risk for non-alcoholic fatty liver disease. | Frontiers in Genetics | 2022 |
| 34633706 | Gut microbiome features associated with liver fibrosis in Hispanics, a population at high risk for fatty liver disease. | Hepatology | 2022 |
| 34730959 | Potent Anti-SARS-CoV-2 Activity by the Natural Product Gallinamide A and Analogues via Inhibition of Cathepsin L. | J Med Chem | 2022 |
| 32974761 | Effect of sarcopenia on systemic targeted therapy response in patients with advanced hepatocellular carcinoma. | Abdominal Radiology | 2021 |
| 33685927 | A Novel Biomarker Panel for the Early Detection and Risk Assessment of Hepatocellular Carcinoma in Patients with Cirrhosis. | Cancer Prevention Research | 2021 |
| 33787221 | A Clinical-Stage Cysteine Protease Inhibitor blocks SARS-CoV-2 Infection of Human and Monkey Cells. | ACS Chem Biol | 2021 |
| 34155064 | Circulating Fatty Acids Associated with Advanced Liver Fibrosis and Hepatocellular Carcinoma in South Texas Hispanics. | Cancer Epidemiol Biomarkers Prev | 2021 |
| 34253566 | Lipidomic Profiles of Plasma Exosomes Identify Candidate Biomarkers for Early Detection of Hepatocellular Carcinoma in Patients with Cirrhosis. | Cancer Prevention Research | 2021 |
| 34299031 | Somatic Mutations in Circulating Cell-Free DNA and Risk for Hepatocellular Carcinoma in Hispanics. | Int J Mol Sci | 2021 |
| 33398273 | Potent <i>in vitro</i> anti-SARS-CoV-2 activity by gallinamide A and analogues via inhibition of cathepsin L. | bioRxiv | 2020 |
| 32258950 | Bile Acid Changes Associated With Liver Fibrosis and Steatosis in the Mexican-American Population of South Texas. | Hepatology Communications | 2020 |
| 32363321 | Multispectral Imaging Enables Characterization of Intrahepatic Macrophages in Patients With Chronic Liver Disease. | Hepatol Commun | 2020 |
| 33305150 | Elevated Glycated Hemoglobin Is Associated With Liver Fibrosis, as Assessed by Elastography, in a Population-Based Study of Mexican Americans. | Hepatology Communications | 2020 |
| 33140046 | A cysteine protease inhibitor blocks SARS-CoV-2 infection of human and monkey cells. | bioRxiv | 2020 |
| 30728499 | Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity. | Nature | 2019 |
| 29902644 | High Prevalence of Hepatic Fibrosis, Measured by Elastography, in a Population-Based Study of Mexican Americans. | Clinical Gastroenterology and Hepatology | 2019 |
| 30699099 | Design of the Texas Hepatocellular Carcinoma Consortium Cohort Study. | American Journal of Gastroenterology | 2019 |
| 29089331 | Prevalence of Aflatoxin-Associated <i>TP53R249S</i> Mutation in Hepatocellular Carcinoma in Hispanics in South Texas. | Cancer Prev Res (Phila) | 2018 |
| 29881823 | Telomerase reverse transcriptase mutations in plasma DNA in patients with hepatocellular carcinoma or cirrhosis: Prevalence and risk factors. | Hepatology Communications | 2018 |
| 30034633 | Toll-like receptor 4: a target for chemoprevention of hepatocellular carcinoma in obesity and steatohepatitis. | Oncotarget | 2018 |
| 29303514 | Depletion of S100A4 stromal cells does not prevent HCC development but reduces the stem cell-like phenotype of the tumors. | Experimental and Molecular Medicine | 2018 |
| 29244873 | Fatty acids in non-alcoholic steatohepatitis: Focus on pentadecanoic acid. | PLoS One | 2017 |
| 28533225 | Multifunctional Effects of a Small-Molecule STAT3 Inhibitor on NASH and Hepatocellular Carcinoma in Mice. | Clinical Cancer Research | 2017 |
| 27560721 | The Precarious Health of Young Mexican American Men in South Texas, Cameron County Hispanic Cohort, 2004-2015. | Preventing chronic disease | 2016 |
| 27339170 | Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population. | Cancer Prev Res (Phila) | 2016 |
| 26731713 | MicroRNA Regulates Hepatocytic Differentiation of Progenitor Cells by Targeting YAP1. | Stem Cells | 2016 |
| 26950933 | Cirrhosis and Advanced Fibrosis in Hispanics in Texas: The Dominant Contribution of Central Obesity. | PLoS One | 2016 |
| 26088260 | Hepatitis C virus in Mexican Americans: a population-based study reveals relatively high prevalence and negative association with diabetes. | Epidemiology and Infection | 2016 |
| 26599259 | Differentiation therapy for hepatocellular carcinoma: Multifaceted effects of miR-148a on tumor growth and phenotype and liver fibrosis. | Hepatology | 2016 |
| 24803312 | Osteopontin and latent-TGF β binding-protein 2 as potential diagnostic markers for HBV-related hepatocellular carcinoma. | Int J Cancer | 2015 |
| 25769721 | miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells. | Cancer Research | 2015 |
| 26085918 | Burden of nonalcoholic fatty liver disease and advanced fibrosis in a Texas Hispanic community cohort. | World J Hepatol | 2015 |
| 26210785 | Quantitative Contrast-Enhanced Ultrasonic Imaging Reflects Microvascularization in Hepatocellular Carcinoma and Prognosis after Resection. | Ultrasound in Medicine and Biology | 2015 |
| 23749645 | Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma. | Cancer Research | 2013 |
| 22106089 | The 2011 Human Liver Proteome Project (HLPP) Workshop September 5, 2011, Geneva, Switzerland. | Proteomics | 2012 |
| 21953299 | Identification of osteopontin as a novel marker for early hepatocellular carcinoma. | Hepatology | 2012 |
| 21731504 | Extracellular matrix dynamics in hepatocarcinogenesis: a comparative proteomics study of PDGFC transgenic and Pten null mouse models. | PLoS Genetics | 2011 |
| 21531903 | The human proteome project: Current state and future direction. | Mol Cell Proteomics | 2011 |
| 21886843 | Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. | PLoS ONE | 2011 |
| 21742803 | The human proteome project: current state and future direction. | Mol Cell Proteomics | 2011 |
| 20092292 | HUPO's effort to define the liver proteome. | Journal of Proteome Research | 2010 |
| 20806223 | The 2009 Human Liver Proteome Project (HLPP) Workshop 26 September 2009, Toronto, Canada. | Proteomics | 2010 |